Quick Answer
PALISADE BIO, INC. reported Net Income Loss of -$16.78 million for the year ending 2025.
- PALISADE BIO, INC. showed a decrease of -16.2% in Net Income Loss from 2024 to 2025.
- This data is from PALISADE BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), PALISADE BIO, INC.'s Net Income Loss has declined by 61.9%.
- Historical annual values: Fiscal year 2025: -$16.78 million | Fiscal year 2024: -$14.44 million | Fiscal year 2023: -$12.30 million | Fiscal year 2022: -$14.26 million | Fiscal year 2021: -$26.62 million | Fiscal year 2020: -$10.32 million | Fiscal year 2019: -$8.35 million | Fiscal year 2018: -$4.92 million | Fiscal year 2017: -$15.67 million | Fiscal year 2016: -$21.07 million | Fiscal year 2015: -$20.90 million | Fiscal year 2014: -$22.63 million | Fiscal year 2013: -$19.83 million | Fiscal year 2012: -$10.12 million | Fiscal year 2011: -$12.52 million | Fiscal year 2010: -$18.39 million | Fiscal year 2009: -$10.36 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: